List view / Grid view

Dr Dominik Schumacher (Chief Executive Officer of Tubulis)

 

article

Next-gen ADCs: Tubulis sets new standard in cancer treatment

Tubulis, led by CEO Dominik Schumacher, is advancing cancer treatment…

23 April 2025 | By

Tubulis, led by CEO Dominik Schumacher, is advancing cancer treatment through next-generation antibody-drug conjugates (ADCs) designed to target solid tumours more effectively. Find out how the company is rapidly progressing its ADC pipeline to offer more precise and lasting treatment options for patients.